NVCR – novocure limited - ordinary shares (US:NASDAQ)
Stock Stats
News
Novocure names Frank Leonard as CEO [Seeking Alpha]
Novocure Appoints Company President Frank Leonard as Chief Executive Officer
Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
Novocure to Participate in 2025 Jefferies Global Healthcare Conference
NovoCure (NASDAQ:NVCR) had its price target raised by analysts at HC Wainwright from $38.00 to $42.00. They now have a "buy" rating on the stock.
Form 8-K NovoCure Ltd For: Nov 24
Form SCHEDULE 13G/A NovoCure Ltd Filed by: Capital World Investors
Form SCHEDULE 13G/A NovoCure Ltd Filed by: Soleus Capital Master Fund, L.P.
Form 4 NovoCure Ltd For: Nov 01 Filed by: Paravasthu Mukund
Form 4 NovoCure Ltd For: Nov 04 Filed by: Brackmann Christoph
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.